Get the Stockscreener App
0.626
5.39%
0.032
Rallybio Corp stock is traded at $0.626, with a volume of 477.36K.
It is up +5.39% in the last 24 hours and up +28.20% over the past month.
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
See More
Previous Close:
$0.594
Open:
$0.591
24h Volume:
477.36K
Relative Volume:
0.17
Market Cap:
$26.16M
Revenue:
-
Net Income/Loss:
$-74.56M
P/E Ratio:
-0.3418
EPS:
-1.8316
Net Cash Flow:
$-60.27M
1W Performance:
+3.64%
1M Performance:
+28.20%
6M Performance:
-16.98%
1Y Performance:
-43.09%
1-Day Range:
$0.59
$0.65
1-Week Range:
$0.53
$0.65
52-Week Range:
$0.2201
$1.25
Rallybio Corp Stock (RLYB) Company Profile
Name
Rallybio Corp
Sector
Industry
Phone
203- 859-3820
Address
234 CHURCH STREET, NEW HAVEN
Compare RLYB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.626 | 26.11M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-15-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-07-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-17-23 | Initiated | H.C. Wainwright | Buy |
| Apr-10-23 | Initiated | Wedbush | Outperform |
| Dec-09-22 | Initiated | JP Morgan | Overweight |
| Feb-22-22 | Initiated | JMP Securities | Mkt Outperform |
| Aug-23-21 | Initiated | Cowen | Outperform |
| Aug-23-21 | Initiated | Evercore ISI | Outperform |
| Aug-23-21 | Initiated | Jefferies | Buy |
View All
Rallybio Corp Stock (RLYB) Latest News
Price Reversal in Rallybio Corporation Traders Watch CloselyRate Hike & Safe Entry Trade Signal Reports - kangso.co.kr
Rallybio Corporation Hits Price Floor — Bounce Incoming2025 Key Highlights & Long-Term Safe Return Strategies - classian.co.kr
Can Rallybio Corporation recover in the next quarterWeekly Trade Review & AI Forecast Swing Trade Picks - Newser
Automated trading signals detected on Rallybio Corporation2025 Technical Overview & Technical Pattern Based Signals - Newser
Can trapped investors hope for a rebound in Rallybio CorporationProduct Launch & Low Drawdown Momentum Trade Ideas - Newser
Myasthenia Gravis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Alpine Immune Science, Toleranzia, Cabaletta Bio, Rallybio, Alexion Pharma, Takeda - The Globe and Mail
What indicators show strength in Rallybio CorporationGlobal Markets & Daily Technical Forecast Reports - Newser
Order Flow Trends Show Accumulation in Rallybio CorporationMarket Activity Summary & Free Accurate Trade Setup Notifications - metrotimes.co.kr
How to integrate Rallybio Corporation into portfolio analysis toolsAnalyst Upgrade & Free Real-Time Market Sentiment Alerts - Newser
Will breakout in Rallybio Corporation lead to full recoveryLong Setup & Real-Time Buy Signal Notifications - Newser
Is Rallybio Corporation meeting your algorithmic filter criteriaJuly 2025 PreEarnings & Precise Buy Zone Identification - Newser
Rallybio Corporation Stock Performance After Earnings: Historical Insights2025 Market WrapUp & Low Drawdown Investment Ideas - Newser
Analyzing recovery setups for Rallybio Corporation investorsWeekly Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Should you wait for a breakout in Rallybio Corporation2025 Buyback Activity & Weekly Stock Breakout Alerts - Newser
Historical volatility pattern of Rallybio Corporation visualizedStop Loss & Daily Entry Point Trade Alerts - Newser
What technical models suggest about Rallybio Corporation’s comebackJuly 2025 PreEarnings & Capital Efficient Trade Techniques - Newser
What is Rallybio Corporation’s book value per share2025 Valuation Update & Scalable Portfolio Growth Methods - thegnnews.com
Rallybio Corporation At Critical Juncture — Bounce or BreakdownJuly 2025 WrapUp & Community Consensus Stock Picks - metal.it
Here's Why Shares in Recursion Pharmaceuticals Surged Today - MSN
Rallybio Corporation stock daily chart insightsJuly 2025 Sector Moves & Stock Portfolio Risk Management - Newser
Will Rallybio Corporation rebound enough to break even2025 Key Lessons & Growth Focused Entry Reports - Newser
Relative strength of Rallybio Corporation in sector analysisPortfolio Performance Report & Technical Confirmation Trade Alerts - Newser
Is a relief rally coming for Rallybio Corporation holdersForecast Cut & Fast Exit/Entry Strategy Plans - Newser
Rallybio Corporation’s volatility index tracking explainedStop Loss & Technical Pattern Based Signals - Newser
Long term hold vs stop loss in Rallybio CorporationJobs Report & Verified Chart Pattern Signals - Newser
Detecting support and resistance levels for Rallybio CorporationJuly 2025 Catalysts & Smart Allocation Stock Reports - Newser
Visual analytics tools that track Rallybio Corporation performanceEarnings Beat & Target Return Focused Stock Picks - Newser
Chart Patterns Forming a Bullish Setup in Rallybio Corporation2025 Momentum Check & Community Consensus Trade Alerts - beatles.ru
Can Rallybio Corporation navigate macro headwinds2025 Year in Review & AI Forecasted Stock Moves - newsyoung.net
Using data models to predict Rallybio Corporation stock movement2025 Dividend Review & Risk Managed Investment Strategies - Newser
Published on: 2025-08-14 17:09:31 - classian.co.kr
Rallybio’s SWOT analysis: c5 inhibitor stock shifts focus amid pipeline changes - Investing.com
Momentum divergence signals in Rallybio Corporation chartMarket Trend Review & Reliable Volume Spike Alerts - Newser
Can trapped investors hope for a rebound in Rallybio Corporation [July 2025 Institutional]Safe Entry Zone Tips - Newser
Is Rallybio Corporation stock entering bullish territoryMarket Downturn Defense Strategy Analysis - Newser
Intraday pattern recognizer results for Rallybio CorporationFast Movement Forecast for Trading Success - Newser
What MACD and RSI say about Rallybio CorporationRisk Aware Trading Ideas with Alert Levels - Newser
Price action breakdown for Rallybio CorporationShort-Term Swing Opportunity Summary Sheet - Newser
Is Rallybio Corporation stock a smart retirement pickBottom Fishing Opportunity - newsyoung.net
What machine learning models say about Rallybio CorporationWeekly Entry Signal Based Forecast Tool - Newser
News impact scoring models applied to Rallybio CorporationFree Fast Gaining Stock Screener Report - Newser
Will Rallybio Corporation bounce back from current supportFree Stock Screener With Smart Filters - Newser
TD Cowen Analyst Maintains Buy Rating for Rallybio. - AInvest
Applying chart zones and confluence areas to Rallybio CorporationWatchlist Summary for Active Day Traders - Newser
Rallybio Corp Stock (RLYB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):